Immunovant, inc. (HSAC)

CashFlow / TTM
Dec'19Sep'19Jun'19Mar'19
Cash flows from operating activities
Net loss

-45,837

0

0

0

Changes in operating assets and liabilities:
Net cash used in operating activities

-30,307

0

0

0

Cash flows from financing activities
Payment of deferred offering costs

3,093

0

0

0

Net cash provided by financing activities

146,696

0

0

0

Net Change in Cash

-

0

0

0